SENORES PHARMACEUTICALS L (SENORES) — Capital Reinvestment Ratio

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L (SENORES) has a Capital Reinvestment Ratio of 3.99x as of September 2025, meaning it reinvests 4% of its operating cash flow (Rs242.20 Million) in capital expenditures (Rs966.90 Million). See SENORES free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

3.99x

Capex / Operating Cash Flow

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L (None–None)

Year-by-year Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L from None to None. For live market cap and broader valuation context, see how much is SENORES PHARMACEUTICALS L worth.

Year	Reinvestment Ratio	Operating CF (INR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow